Fignon’s cancer is bound to reignite debate about the potential grave medical consequences from the taking of performance enhancing drugs, writes Ross Stapleton.
Fignon’s cancer is bound to reignite debate about the potential grave medical consequences from the taking of performance enhancing drugs, writes Ross Stapleton.